FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, more specifically to pharmacology, and concerns using 4-methyl-2,6-diisobornylphenol as a high-activity drug possessing the anti-ischemic properties.
EFFECT: preparing the high-activity drug possessing the anti-ischemic properties.
3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIISHEMIC AGENT | 2008 |
|
RU2384327C1 |
AGENT RELIEVING POSTINFARCTION MYOCARDIAL REMODELING | 2020 |
|
RU2740895C1 |
RETINOPROTECTOR | 2009 |
|
RU2406487C1 |
AGENT POSSESSING ENDOTHELIUM PROTECTIVE ACTIVITY | 2014 |
|
RU2563622C1 |
NEUROPROTECTOR | 2009 |
|
RU2406488C1 |
MEANS IMPROVING MICROVASCULARIZATION IN BRAIN TISSUE | 2017 |
|
RU2650624C1 |
AGENT POSSESSING NEUROPROTECTIVE ACTIVITY | 2018 |
|
RU2701739C1 |
AGENT STIMULATING NEUROGENESIS IN ISCHEMIC CEREBRAL INJURIES | 2015 |
|
RU2585094C1 |
HYDROPHILIC CONJUGATE OF HYDROXYETHYL STARCH AND 2,6-DIISOBORNYL-4-METHYLPHENOL | 2012 |
|
RU2497828C1 |
NOVEL DERIVATIVES OF 2,6-DI-ISOBORNYL PHENOL AND METHOD OF OBTAINING THEREOF | 2012 |
|
RU2516699C2 |
Authors
Dates
2013-11-27—Published
2012-10-24—Filed